ABSITE - Anesthesia - questions
and verified answers ( detailed &
elaborated) ACTUAL EXAM 2026
TEST!
Tx interventions for ARDS w/ mortality benefit -
CORRECT ANSWERS 1) lung protective
ventilation w/tidal volume=6ml/kg
2) prone positioning
First mets for gallbladder cancer aka porcelain gallbladder
- CORRECT ANSWERS cystic duct nodes
Ewing sarcoma - CORRECT ANSWERS
"Onion skin/peel" periosteal reaction
Most commonly in bony pelvis
, Pembrolizumab (Target & use) - CORRECT ANSWERS
PD-L1 (programmed death ligand 1) and Non-small cell
lung cancer
Ipilimumab (Target & Use) - CORRECT ANSWERS
CTLA-4 (cytotoxic t-lymphocyte antigen)
Melanoma
Selpercatinib (Target & Use) - CORRECT ANSWERS
RET
Medullary thyroid cancer in MEN 2a/2b
Anastrozole (Target & Use) - CORRECT ANSWERS
Aromatase inhibitor
ER+ breast cancer
Trastuzumab (Target & Use) - CORRECT ANSWERS
HER2 Receptor
HER2+ breast cancer
and verified answers ( detailed &
elaborated) ACTUAL EXAM 2026
TEST!
Tx interventions for ARDS w/ mortality benefit -
CORRECT ANSWERS 1) lung protective
ventilation w/tidal volume=6ml/kg
2) prone positioning
First mets for gallbladder cancer aka porcelain gallbladder
- CORRECT ANSWERS cystic duct nodes
Ewing sarcoma - CORRECT ANSWERS
"Onion skin/peel" periosteal reaction
Most commonly in bony pelvis
, Pembrolizumab (Target & use) - CORRECT ANSWERS
PD-L1 (programmed death ligand 1) and Non-small cell
lung cancer
Ipilimumab (Target & Use) - CORRECT ANSWERS
CTLA-4 (cytotoxic t-lymphocyte antigen)
Melanoma
Selpercatinib (Target & Use) - CORRECT ANSWERS
RET
Medullary thyroid cancer in MEN 2a/2b
Anastrozole (Target & Use) - CORRECT ANSWERS
Aromatase inhibitor
ER+ breast cancer
Trastuzumab (Target & Use) - CORRECT ANSWERS
HER2 Receptor
HER2+ breast cancer